Development, validation and analytical error function of two chromatographic methods with fluorimetric detection for the determination of bisoprolol and metoprolol in human plasma

被引:46
作者
Braza, AJ [1 ]
Modamio, P [1 ]
Lastra, CF [1 ]
Mariño, EL [1 ]
机构
[1] Univ Barcelona, Fac Pharm, Pharm & Pharmaceut Technol Dept, Clin Pharm & Pharmacotherapy Unit,Hlth Div, E-08028 Barcelona, Spain
关键词
D O I
10.1002/bmc.195
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This work describes two high-performance liquid chromatographic methods for the individual determination of bisoprolol and metoprolol in human plasma. Analytical methods involve two different liquid-liquid extractions of human plasma, with diethyl ether for bisoprolol and with dichloromethane for metoprolol, coupled with a similar Nucleosil C-18 reversed-phase HPLC column. Fluorimetric detection was used to identify both beta-blockers. Retention times for bisoprolol and metoprolol were 8.7 and 3.2 min, respectively,. Linear regressions for the calibration curves were linear at a concentration range of 6.25-200 ng/mL. Intra- and inter-day precision coefficients of variations and accuracy bias were acceptable (within 15%) over the entire range for both drugs. Average recovery was 89% for metoprolol and 98% for bisoprolol. Once the methods had been validated, analytical error functions were established as standard deviation (SD; ng/mL) = 2.216 + 3.608 x 10(-4)C(2) (C = theoretical concentration value) and SD (ng/mL) = 0.408 + 0.378 x 10(-1)C for bisoprolol and metoprolol, respectively. The methods developed and their associated analytical error functions will be suitable for pharmacokinetic studies and for determination of plasma concentration if posology, individualization of these drugs is needed. Copyright (C) 2002 John Wiley Sons, Ltd.
引用
收藏
页码:517 / 522
页数:6
相关论文
共 18 条
[1]   Optimization of mobile phase in the separation of β-blockers by HPLC [J].
Basci, NE ;
Temizer, A ;
Bozkurt, A ;
Isimer, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1998, 18 (4-5) :745-750
[2]   Determination of celiprolol and oxprenolol in human plasma by high-performance liquid chromatography and the analytical error function [J].
Braza, AJ ;
Modamio, P ;
Mariño, EL .
JOURNAL OF CHROMATOGRAPHY B, 1998, 718 (02) :267-272
[3]   Two reproducible and sensitive liquid chromatographic methods to quantify atenolol and propranolol in human plasma and determination of their associated analytical error functions [J].
Braza, AJ ;
Modamio, P ;
Mariño, EL .
JOURNAL OF CHROMATOGRAPHY B, 2000, 738 (02) :225-231
[4]   Validation of chromatographic methods in biomedical analysis - Viewpoint and discussion [J].
Causon, R .
JOURNAL OF CHROMATOGRAPHY B, 1997, 689 (01) :175-180
[5]  
Deroubaix X, 1996, INT J CLIN PHARM TH, V34, P61
[6]  
Huber L., 1998, LC GC EUR, V11, P96
[7]  
Jansat JM, 1998, INT J CLIN PHARM TH, V36, P340
[8]   Model-based, goal-oriented, individualised drug therapy - Linkage of population modelling new 'multiple model' dosage design, Bayesian feedback and individualised target goals [J].
Jelliffe, RW ;
Schumitzky, A ;
Bayard, D ;
Milman, M ;
Van Guilder, M ;
Wang, X ;
Jiang, F ;
Barbaut, X ;
Maire, P .
CLINICAL PHARMACOKINETICS, 1998, 34 (01) :57-77
[9]  
JELLIFFE RW, 1989, DRUG MONIT TOXICOL, V10, P1
[10]  
Kleinbaum DG., 1988, STUDENTS PARTIAL SOL, Vvol 601